candesartan cilexetil has been researched along with Cerebrovascular Disorders in 3 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, S | 1 |
Ohta, K | 1 |
Hamaguchi, A | 1 |
Omura, T | 1 |
Yukimura, T | 1 |
Miura, K | 1 |
Inada, Y | 2 |
Wada, T | 2 |
Ishimura, Y | 2 |
Chatani, F | 1 |
Ojima, M | 1 |
Sanada, T | 1 |
Shibouta, Y | 1 |
Kanagawa, R | 1 |
Fujisawa, Y | 1 |
Nishikawa, K | 2 |
1 review available for candesartan cilexetil and Cerebrovascular Disorders
Article | Year |
---|---|
Angiotensin AT1 receptor antagonism and protection against cardiovascular end-organ damage.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compoun | 1998 |
2 other studies available for candesartan cilexetil and Cerebrovascular Disorders
Article | Year |
---|---|
Renal protective effect of TCV-116 in stroke-prone spontaneously hypertensive rats.
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Ben | 1994 |
Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Angiote | 1997 |